Gene · 5142
Papers1,785
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,785
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genome-wide association study of thyroid-stimulating hormone highlights new genes, pathways and associations with thyroid disease. | Nat Commun | 2023 | 37872160 | PubTator, text mining | PubMed |
| Single cell RNA-sequencing analysis reveals that N-acetylcysteine partially reverses hepatic immune dysfunction in biliary atresia. | JHEP Rep | 2023 | 37869073 | PubTator, text mining | PubMed |
| IgG immune complex-induced acute lung injury is ameliorated by cAMP via down-regulation of C/EBP- and AP-1-mediated transcriptions. | J Inflamm (Lond) | 2023 | 37864223 | PubTator, text mining | PubMed |
| Establishment and validation of a novel risk model based on CD8T cell marker genes to predict prognosis in thyroid cancer by integrated analysis of single-cell and bulk RNA-sequencing. | Medicine (Baltimore) | 2023 | 37861558 | PubTator, text mining | PubMed |
| Phosphorylation-Assisted Luciferase Complementation Assay Designed to Monitor Kinase Activity and Kinase-Domain-Mediated Protein-Protein Binding. | Int J Mol Sci | 2023 | 37834301 | PubTator, text mining | PubMed |
| Revisiting the roles of cAMP signalling in the progression of prostate cancer. | Biochem J | 2023 | 37830741 | PubTator, text mining | PubMed |
| ZSP1601, a novel pan-phosphodiesterase inhibitor for the treatment of NAFLD, A randomized, placebo-controlled phase Ib/IIa trial. | Nat Commun | 2023 | 37828034 | PubTator, text mining | PubMed |
| Meta-analysis of lean and obese RNA-seq datasets to identify genes targeting obesity. | Bioinformation | 2023 | 37808366 | PubTator, text mining | PubMed |
| The molecular regulatory mechanisms of meiotic arrest and resumption in Oocyte development and maturation. | Reprod Biol Endocrinol | 2023 | 37784186 | PubTator, text mining | PubMed |
| GWAS Meta-Analysis of Suicide Attempt: Identification of 12 Genome-Wide Significant Loci and Implication of Genetic Risks for Specific Health Factors. | Am J Psychiatry | 2023 | 37777856 | PubTator, text mining | PubMed |
| Imidazoles as Serotonin Receptor Modulators for Treatment of Depression: Structural Insights and Structure-Activity Relationship Studies. | Pharmaceutics | 2023 | 37765177 | PubTator, text mining | PubMed |
| Development of a Macrophage-Related Risk Model for Metastatic Melanoma. | Int J Mol Sci | 2023 | 37762054 | PubTator, text mining | PubMed |
| Hematopoietic Stem Cells Transplant (HSCT)-Related Chronic Pulmonary Diseases: An Overview. | Children (Basel) | 2023 | 37761496 | PubTator, text mining | PubMed |
| Re-Addressing Dementia by Network Medicine and Mechanism-Based Molecular Endotypes. | J Alzheimers Dis | 2023 | 37742653 | PubTator, text mining | PubMed |
| Circular RNAs in the human brain are tailored to neuron identity and neuropsychiatric disease. | Nat Commun | 2023 | 37723137 | PubTator, text mining | PubMed |
| Add-on therapy for pulmonary fibrosis, a forthcoming era with implications for practice: the BI 101550 and RELIEF trials. | Breathe (Sheff) | 2023 | 37719242 | PubTator, text mining | PubMed |
| CircNCOA4 knockdown attenuates OGD-induced neuron injury through miR-338-5p/PDE4B axis. | Exp Brain Res | 2023 | 37716929 | PubTator, text mining | PubMed |
| Beyond epithelial damage: vascular and endothelial contributions to idiopathic pulmonary fibrosis. | J Clin Invest | 2023 | 37712420 | PubTator, text mining | PubMed |
| Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with progressive pulmonary fibrosis (FIBRONEER-ILD). | BMJ Open Respir Res | 2023 | 37709661 | PubTator, text mining | PubMed |
| Epigenomic signature of accelerated ageing in progeroid Cockayne syndrome. | Aging Cell | 2023 | 37688320 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5142/papers?page=11